U.S. Software Stock News

Automatic Data Processing (ADP) stock is in focus after recent ADP National Employment Report updates showed U.S. private sector hiring slowing for the sixth straight week, signaling a cooler labor market backdrop for investors. See our latest analysis for Automatic Data Processing. At a share price of $271.09, Automatic Data Processing has seen a 12.06% 1 month share price return and a 29.94% 3 month share price return, while the 1 year total shareholder return is down 7.01%. This suggests...

Norwegian Cruise Line Holdings recently reported past second-quarter 2026 results showing higher revenue of US$910.71 million and net income of US$222.55 million, alongside updated guidance calling for occupancy of about 104.0% in the third quarter and around 102.3% for full-year 2026. At the same time, the company filed a US$163.19 million shelf registration for 8,807,000 ordinary shares tied to an employee stock ownership plan, highlighting ongoing efforts to align employees with business...

Q2 Holdings (QTWO) stock is in focus after the company reported second quarter 2026 results, with higher sales and net income compared with a year earlier, alongside raised full year revenue and adjusted EBITDA guidance. See our latest analysis for Q2 Holdings. At a share price of $63.36, Q2 Holdings has seen a 22.25% 1 month share price return and a 41.74% 3 month share price return, while the 1 year total shareholder return is down 15.68% and the 5 year total shareholder return is down...

Rocket Lab stock barely moved after earnings, slipping just 0.04% to about $80. That calm surface hides a real sentiment split. Bulls are pointing to record Q2 revenue of $234.1m and a backlog that management pegs at about $2.36b. Bears are focused on the ongoing net loss of $49.3m and the reminder that this is still a cash burning space player. Today's flat trading suggests investors are unsure whether to emphasize the top line results or the profitability challenges that remain. Is Rocket...

In recent weeks, Micron Technology has highlighted that AI-driven demand is keeping high-bandwidth memory and DRAM supplies tight through at least 2027, even as it reports record revenue, margin expansion, and presents its latest technologies at industry forums like the Future of Memory and Storage 2026. The company is reshaping its business model with long-term, take-or-pay customer agreements and a planned US$250.00 billion U.S. investment program, aiming to secure multi-year volume,...

BRT Apartments stock barely flinched after earnings, slipping only 0.3% to about US$14, even though the headline story is not about profit at all. For a residential REIT, the real heartbeat is Funds From Operations, and BRT printed roughly US$5.5m in the quarter against a reported net loss of US$3.4m. The market seems to be shrugging because that contrast between cash style earnings and accounting losses is already baked in. The real question for you now is how comfortable you are with that...

Why Intuit Stock Is Back in Focus After Its AI ERP Launch Intuit (INTU) is drawing fresh attention after the launch of its AI native Intuit Enterprise Suite with Citrin Cooperman Advisors, in a move aimed at mid market ERP projects and finance automation for multi entity businesses. See our latest analysis for Intuit. The AI Enterprise Suite launch comes after a sharp reset in Intuit’s stock, with a 22.36% 1 month share price return suggesting momentum is rebuilding even though the year to...

SEALSQ (LAES) is back on investors’ radar after appointing Daniel Brau as Chief Quantum Officer, following its full acquisition of Swiss quantum photonics firm Miraex. This move ties leadership directly to its expanding quantum platform ambitions. See our latest analysis for SEALSQ. Despite the quantum-focused announcements in late July and early August, SEALSQ’s share price return is still down about 40% year to date and the 3 year total shareholder return has declined about 72%, which...

ResMed (RMD) has given income focused investors fresh information to consider after it declared a quarterly dividend of $0.66 per share, a 10% increase, alongside its latest earnings and buyback update. See our latest analysis for ResMed. ResMed shares have recently picked up some momentum, with a 30 day share price return of 10.29% and a 90 day return of 11.10%. However, the year to date share price performance is down 8.16% and the 1 year total shareholder return has declined 19.86%, while...

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Futu Holdings Limited over past statements on its business operations and regulatory compliance in China, covering investors who bought securities between May 24, 2023 and May 27, 2026. The lawsuit’s focus on alleged misrepresentations around Chinese regulatory compliance could have meaningful implications for how investors assess Futu’s risk profile and disclosures. We’ll now examine how allegations around Futu’s Chinese...

What the new Stripe integration could mean for Synchrony stock Synchrony Financial (SYF) has drawn fresh attention after announcing a new integration with Stripe that brings its CareCredit financing into Stripe’s online checkout for U.S. health and wellness providers. The partnership lets existing and new Stripe health and wellness users activate CareCredit directly in their Stripe Dashboard, without extra integrations. That creates a single hub for payment methods, reporting, reconciliation,...

What Coinbase Global’s UK derivatives launch means for investors Coinbase Global (COIN) has started offering leveraged derivatives trading to professional investors in the UK, including perpetuals, futures, and options across crypto, commodities, equities, and foreign exchange markets. This launch follows Coinbase Global’s recent moves into US stock trading and crypto perpetuals in Australia and positions the company as a regulated provider of a wider set of products for international...

With the S&P 500 sitting at record levels and trading at 28 times earnings, investors are weighing strong AI driven corporate results against the risk that expectations are set too high. That mix of optimism and unease can create openings that feel easy to miss. This article walks through three large cap stocks from our U.S. index funds screener that are closely tied to this earnings story and explains how today’s setup could matter for your long term portfolio. The three stocks highlighted...

eToro Group walked into this earnings print with sentiment already frayed. The stock was down about 29% over the past three months, then dropped another 14% today to close near US$29. That kind of one day slump suggests traders are reacting emotionally to a softer second quarter revenue line rather than the full picture. The headline is that eToro still produced profitable growth, with Q2 net income of US$53.48m and basic earnings per share of US$0.65 on revenue of US$1.55b. The real question...

AECOM walked into this earnings season wearing the label of an underappreciated infrastructure play with solid long term growth credentials. Today the market slammed the stock anyway. The share price dropped 8.5% to about $67 after the company reported a quarterly loss and booked a heavy $337m pretax charge on a troubled construction management project. For investors, the headline is simple. AECOM just posted a sharp earnings hit driven by one project, while still pointing to record backlog...

Quanterix stock jumped about 8% to US$2.63 after earnings, a sharp move for a company that came into this week with double digit declines over the past month. The market is reacting to a very different story compared with the old high growth diagnostics promise. The headline this quarter is margin and cash discipline. Quanterix posted Q2 revenue of US$32.9 million while reporting a sizeable net loss and cutting full year revenue guidance to a range of US$142 million to US$148 million. The...

Cardinal Health entered this earnings week on a strong run, with the stock already up over the past quarter and edging another 1.3% higher to about US$240 by the close. The market reaction was positive but restrained for a distributor that just printed adjusted free cash flow of US$5.0b and full year revenue of US$254b. That gap between a modest price move and very large cash generation is the real story for you as a shareholder. Is Cardinal Health a rare case where a rich P/E and heavy debt...

Motorcar Parts of America walked into this earnings season with a stock that had drifted down in recent weeks and then barely budged on the print, closing up just 0.2% at US$12.45. That muted move masks a jarring headline. The company swung from a recent quarterly profit to a loss of US$13.4m in Q1 on revenue of US$168.0m. For an auto parts supplier that many investors view as a recovery and margin story, this quarter puts the squeeze in full view. The rest of the year now has to answer...

Northern Oil and Gas, Inc. recently reported second-quarter 2026 results, with revenue of US$745.24 million and net income of US$236.63 million, alongside unaudited production of 145,659 Boe per day and reaffirmed full-year 2026 production guidance and a US$0.45 per-share dividend. While six-month results showed lower revenue of US$750.26 million and a loss of US$286.22 million, the sharp quarterly earnings improvement and increased natural gas output give investors a more nuanced view of...

Oil prices remain sensitive to events in the Middle East, which keeps inflation expectations and defense priorities in focus for governments that rely on energy imports. That backdrop draws attention to companies in the Aerospace and Defense screener, which sit close to major spending decisions. For investors who do not want to sit on the sidelines, this article highlights 3 stocks from the screener that may warrant closer examination. The 3 Aerospace and Defense stocks below are just a...

Accendra Health stock closed at US$1.26, down 10% on the day, as investors reacted to another quarter in the red. The headline is not the revenue line. The real story is the squeeze in profitability, with Q2 basic earnings per share at a loss of US$1.16 and net income excluding extra items also in loss territory. For a home based health provider already dealing with high volatility and balance sheet pressure, that profit strain matters more than the single-day move. The key question now is...

Park Hotels & Resorts Inc. recently reported past second-quarter 2026 results, with revenue of US$680 million and net income of US$47 million, marking a move from a loss to profit year over year. Over the first half of 2026, the company maintained flat revenue of US$1.30 billions while turning a prior net loss into US$58 million of net income, and affirmed a quarterly dividend of US$0.25 per share payable in October 2026. With this swing to profitability now on the books, we’ll explore how...

AirSculpt Technologies just jumped 16.9% to about US$3.22, even though this stock has spent the past three months grinding lower. The spark was not a clean return to profits. It was a margin story in a turnaround quarter. Q2 revenue landed at US$42.9 million, while adjusted earnings before interest, tax, depreciation and amortization came in at US$4.9 million with gross margin around 61%. For a business still posting losses, that level of gross profitability is what the market latched onto...

IDEXX Laboratories (NasdaqGS:IDXX) has launched the Catalyst proBNP Test, the first dual-species point-of-care NT-proBNP cardiac assay for companion animals. The new test enables real-time cardiac assessment for both dogs and cats at veterinary clinics. The Catalyst proBNP Test expands IDEXX Laboratories' in-clinic diagnostic menu for cardiac disease in pets. This move into real-time cardiac diagnostics at the clinic level fits into a broader shift toward data driven tools in animal and...